GANX
Gain Therapeutics, Inc.
Key Financials
Net Income
$-20161099
↑ 1.2%
Revenue
$55180
0.0%
Operating Income
$-18710702
↑ 8.1%
EPS (Diluted)
$-0.61
↑ 31.5%
Total Liabilities
$4.3M
↓ 11.1%
Cash & Equivalents
$20.8M
↑ 100.6%
Total Assets
$22.8M
↑ 88.2%
Operating Cash Flow
$-18465432.00
↑ 2.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GANX |
| Company Name | Gain Therapeutics, Inc. |
| CIK | 1819411 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (301) 500-1556 |